Latest News

Yale's Center for Infection & Immunity, directed by Akiko Iwasaki, PhD, will lead the funded research.

A Yale-led study found that unsaturated fats such as those found in olive oil can alleviate symptoms of colitis in mice.

A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.

A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.

The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.

Two Yale labs will lead projects, in collaboration with other leading universities, tasked with developing new approaches to understand and combat pathogens.

Despite the critical role of neutrophils in the human immune system, no one has been able to study them in a living context, limiting investigations of their properties. But now, a team of Yale researchers has developed the first humanized mouse model that will permit research on neutrophils in vivo.

The funding is for six innovative research projects that exhibit the potential to develop new diagnostics and therapeutics and to provide new insights into the mechanistic underpinnings of autoimmune diseases.

The Howard Hughes Medical Institute (HHMI) has provided $10 million to HHMI Investigators at Yale, an HHMI host institution. The funding supports collaborative research projects through the labs of some of the leading experts at the forefront of COVID-19 research.